FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door
This article was originally published in The Tan Sheet
Executive Summary
USPlabs says it will reformulate its DMAA supplements, although it “stands by the safety and legality” of the products. FDA says “credible science” shows DMAA is not a botanical, not a dietary ingredient and will not be accepted in an NDI notification.
You may also be interested in...
FDA Using “All Available Tools” To Remove DMAA From Market
FDA issues a consumer warning about the potentially lethal effects of DMAA, and promises to use “all available tools at its disposal to ensure the dietary supplements containing” the stimulant “are no longer distributed and available for sale.”
DMAA Supplements Banned In U.K., Hamstrung In U.S.
The Medicines and Healthcare products Regulatory Agency bans use of dimethylamylamine in the United Kingdom. Meanwhile, FDA has stopped short of an all-out ban, though retailers and insurance carriers largely have turned their backs on DMAA.
DMAA Warnings Shed Light On FDA NDI Enforcement
FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.